CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 258 enrolled
Drug / intervention
Regular, pharmacy based interventionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01692119
NCT01692119N/ACompleted

Pharmacy-based Interdisciplinary Program for Patients With Chronic Heart Failure (PHARM-CHF): A Randomized Controlled Trial

Federal Union of German Associations of Pharmacists·interventional·Posted Sep 25, 2012·Updated Apr 22, 2021

In Brief

A clinical study evaluating Regular, pharmacy based intervention for Chronic Heart Failure. Completed, enrolled 258 participants across 1 site.

Detailed Summary

The aim of the study is to investigate whether a continuous interdisciplinary intervention improves medication adherence (primary efficacy endpoint) and leads to a reduction of hospitalizations and mortality (primary safety endpoint) in elderly patients with chronic heart failure. The intervention, consisting of regular contacts with the local pharmacy and weekly dosing aids, aims to improve medication adherence and management.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesGermany

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 25, 2012
Enrollment StartOct 1, 2012
Primary CompletionJun 1, 2018
Study CompletionMar 1, 2019
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 13.8 years ago

Interventions

Regular, pharmacy based interventionbehavioral

Regular, pharmacy-based intervention conducted in cooperation with the treating physician: * Medication review at baseline: recording of all medicines currently taken (prescribed medication and self-medication), check for drug-related problems, consolidation of a medication plan. * Regularly (weekly): dose-dispensing of the medication (weekly dosing aid), discussion and counseling regarding medication, adherence, potential side effects, and signs and symptoms of cardiac decompensation; blood pressure and pulse measurement. If required: contact with patients' physician.